ENTITY

Neurocrine Biosciences (NBIX US)

29
Analysis
Health CareUnited States
Neurocrine Biosciences, Inc. is focused on the discovery and development of therapeutics for neuropsychiatric, neuroinflammatory, and neurodegenerative diseases and disorders. The Company is developing therapeutic interventions for anxiety, depression, Alzheimer's disease, insomnia, stroke, malignant brain tumors, multiple sclerosis, obesity, and diabetes.
more
Company Presentation29 Oct 2025 04:30
Company Presentation31 Jul 2025 04:30
Company Presentation06 May 2025 04:30
Company Presentation07 Feb 2025 05:30
Company Presentation30 Oct 2024 20:00
x